As expected, the angiogenesis pathway was significantly upregulated in the plasma of TSC-RAML patients, which was in accordance with the pathological process of angiomyolipoma biosynthesis (Xian et al., 2011). The gene discussed is TSC1; the disease is kidney angiomyolipoma.